These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Intraportal hyperinsulinemia decreases insulin-stimulated glucose uptake in the dog. McGuinness OP; Friedman A; Cherrington AD Metabolism; 1990 Feb; 39(2):127-32. PubMed ID: 2405232 [TBL] [Abstract][Full Text] [Related]
24. Chronic ethanol-induced insulin resistance is associated with macrophage infiltration into adipose tissue and altered expression of adipocytokines. Kang L; Sebastian BM; Pritchard MT; Pratt BT; Previs SF; Nagy LE Alcohol Clin Exp Res; 2007 Sep; 31(9):1581-8. PubMed ID: 17624994 [TBL] [Abstract][Full Text] [Related]
25. Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene. Rossetti L; Stenbit AE; Chen W; Hu M; Barzilai N; Katz EB; Charron MJ J Clin Invest; 1997 Oct; 100(7):1831-9. PubMed ID: 9312184 [TBL] [Abstract][Full Text] [Related]
26. The effect of systemic venous drainage of the pancreas on insulin sensitivity in dogs. Radziuk J; Barron P; Najm H; Davies J J Clin Invest; 1993 Oct; 92(4):1713-21. PubMed ID: 8104957 [TBL] [Abstract][Full Text] [Related]
27. Increased forearm blood flow during glucose clamp is related neither to insulin sensitivity nor to hyperinsulinemia in borderline hypertensive young men. Høieggen A; Fossum E; Moan A; Rostrup M; Eide IK; Kjeldsen SE Blood Press; 1999; 8(4):227-32. PubMed ID: 10697303 [TBL] [Abstract][Full Text] [Related]
28. Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy. Christopher M; Hew FL; Oakley M; Rantzau C; Alford F J Clin Endocrinol Metab; 1998 May; 83(5):1668-81. PubMed ID: 9589675 [TBL] [Abstract][Full Text] [Related]
29. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients. Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493 [TBL] [Abstract][Full Text] [Related]
30. Twenty-four hour energy expenditure and skeletal muscle gene expression changes after bariatric surgery. Iesari S; le Roux CW; De Gaetano A; Manco M; Nanni G; Mingrone G J Clin Endocrinol Metab; 2013 Feb; 98(2):E321-7. PubMed ID: 23341487 [TBL] [Abstract][Full Text] [Related]
31. Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity. Baron AD; Zhu JS; Zhu JH; Weldon H; Maianu L; Garvey WT J Clin Invest; 1995 Dec; 96(6):2792-801. PubMed ID: 8675649 [TBL] [Abstract][Full Text] [Related]
32. Evidence for direct action of alloxan to induce insulin resistance at the cellular level. Ader M; Richey JM; Bergman RN Diabetologia; 1998 Nov; 41(11):1327-36. PubMed ID: 9833941 [TBL] [Abstract][Full Text] [Related]
33. Regulation of muscle malonyl-CoA levels in the nutritionally insulin-resistant desert gerbil, Psammomys obesus. Shafrir E; Ziv E; Saha AK; Ruderman NB Diabetes Metab Res Rev; 2002; 18(3):217-23. PubMed ID: 12112940 [TBL] [Abstract][Full Text] [Related]
34. Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat. Broca C; Breil V; Cruciani-Guglielmacci C; Manteghetti M; Rouault C; Derouet M; Rizkalla S; Pau B; Petit P; Ribes G; Ktorza A; Gross R; Reach G; Taouis M Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E463-71. PubMed ID: 15082420 [TBL] [Abstract][Full Text] [Related]
35. Co-administration of etomoxir and RU-486 mitigates insulin resistance in hepatic and muscular tissues of STZ-induced diabetic rats. Bitar MS Horm Metab Res; 2001 Oct; 33(10):577-84. PubMed ID: 11607876 [TBL] [Abstract][Full Text] [Related]
36. Effect of hepatic denervation on peripheral insulin sensitivity in conscious dogs. Moore MC; Satake S; Baranowski B; Hsieh PS; Neal DW; Cherrington AD Am J Physiol Endocrinol Metab; 2002 Feb; 282(2):E286-96. PubMed ID: 11788359 [TBL] [Abstract][Full Text] [Related]
37. High-fat- and lipid-induced insulin resistance in rats: the comparison of glucose metabolism, plasma resistin and adiponectin levels. Li L; Yang G; Li Q; Tang Y; Li K Ann Nutr Metab; 2006; 50(6):499-505. PubMed ID: 17191023 [TBL] [Abstract][Full Text] [Related]
38. Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion. Jessen N; Djurhuus CB; Jørgensen JO; Jensen LS; Møller N; Lund S; Schmitz O Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E194-9. PubMed ID: 15339744 [TBL] [Abstract][Full Text] [Related]
39. Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis. Lucidi P; Rossetti P; Porcellati F; Pampanelli S; Candeloro P; Andreoli AM; Perriello G; Bolli GB; Fanelli CG Diabetes; 2010 Jun; 59(6):1349-57. PubMed ID: 20299466 [TBL] [Abstract][Full Text] [Related]
40. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside renders glucose output by the liver of the dog insensitive to a pharmacological increment in insulin. Camacho RC; Lacy DB; James FD; Donahue EP; Wasserman DH Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1039-43. PubMed ID: 16046457 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]